Oliver Jacqueline E, Worthington Jane, Silman Alan J
arc Epidemiology Unit, Manchester University, School of Epidemiology and Health Sciences, Manchester, UK.
Curr Opin Rheumatol. 2006 Mar;18(2):141-6. doi: 10.1097/01.bor.0000209425.84775.23.
This review aims to summarize articles published between October 2004 and November 2005 that have investigated the genetic epidemiology of rheumatoid arthritis.
The consistent replication of an association between the R620W single nucleotide polymorphism in PTPN22 and rheumatoid arthritis clearly establishes this polymorphism as an important risk factor for rheumatoid arthritis.
Genetic investigations of rheumatoid arthritis have predominantly been single nucleotide polymorphism-based candidate gene association studies searching for markers of susceptibility, severity or treatment response. Studies of the human leukocyte antigen region have refined and added to our understanding of the complex associations to polymorphisms with this locus. PTPN22 has emerged strongly as a genuine rheumatoid arthritis susceptibility gene with replications of the association to the R620W single nucleotide polymorphism. Many investigations have been conducted on the genetics of treatment response -- some 'generic' and others specific in terms of identifying genetic influences to the mode of action and metabolism of particular agents.
本综述旨在总结2004年10月至2005年11月期间发表的有关类风湿关节炎遗传流行病学的研究文章。
PTPN22基因中R620W单核苷酸多态性与类风湿关节炎之间关联的一致重复,明确将该多态性确立为类风湿关节炎的重要危险因素。
类风湿关节炎的遗传学研究主要是基于单核苷酸多态性的候选基因关联研究,旨在寻找易感性、严重程度或治疗反应的标志物。对人类白细胞抗原区域的研究完善并加深了我们对该基因座多态性复杂关联的理解。PTPN22已强有力地成为真正的类风湿关节炎易感基因,其与R620W单核苷酸多态性的关联得到重复验证。关于治疗反应的遗传学已经进行了许多研究——一些是“通用的”,另一些则是在确定特定药物作用方式和代谢的遗传影响方面具有特异性。